Background Intellectual deterioration occurs in 10-40% of patients with Parkinson's disease. However, there are many conflicting studies on its relation with brain perfusion and the nature of this dementing process remains controversial.
Introduction
In Parkinson's disease, the striatum dopamine amount decreases due to degeneration of the substantia nigra, causing peculiar and various movement disorders. In addition, intellectual deterioration occurs in 10-40% of patients with Parkinson's disease (1, 2), especially in the delayed onset and akinetic-rigid forms of the disease (3, 4) . However, the nature of this dementing process and particularly its relationship with Alzheimer's disease remain controversial (5, 6) .
Measurement of regional cerebral blood flow (rCBF) using positron emission tomography (PET) or single photon emission computed tomography (SPECT) techniques provide a useful approach to the study of human degenerative dementias (7) . Although there is general agreement that a global reduction in rCBF and metabolism predominantly affecting the parieto-temporal regions is encountered in Alzheimer's disease, the available data in Parkinson's disease are conflicting, and do not demonstrate distinctions in specific patterns of rCBF or metabolism between Parkinson's disease with or without dementia (8) (9) (10) (11) . One of the reasons may be that many factors contribute to the pathophysiology of dementia in Parkinson's disease, such as Alzheimer's disease-like mechanism, diffuse Lewy body disease-like factor or frontal dysfunction due to Parkinson's disease itself. Therefore, the usefulness of conventional group comparisons may be limited.
In this study, we used a multiple logistic regression model to overcome this limitation. We divided the patients into those with and without dementia, then regional cerebral perfusion was measured by SPECT using N-isopropyl-p-123 I iodoamphetamine ( 123 I-IMP) as a tracer. The aim of this study was to compare cortical perfusion between Parkinson's disease patients with dementia and those without dementia and investigate the correlation between dementia in Parkinson's disease and brain perfusion in various areas.
Subjects and Methods

Subjects
Fifty-two cases of Parkinson's disease were studied. All of the patients fulfilled the UK Parkinson's Disease Society Brain Bank criteria for idiopathic Parkinson's disease (12) , and levodopa treatment was effective for parkinsonian symptoms in all patients. Careful informed consent was obtained from all patients before participation in this study. There were no cases complicated by any other central nervous disease. Patients suspected of other forms of parkinsonism such as diffuse Lewy body disease (13) or multiple system atrophy (14) were not enrolled. We differentiated patients with diffuse Lewy body disease from those with Parkinson's disease with dementia by the one-year rule (13) . We performed the Mini-Mental State Examination (MMSE), Revised version of Hasegawa's Dementia Scale (HDS-R), Frontal Assessment Battery (FAB) and SPECT within the same time period. We divided the patients into two groups: the dementia group (PDD) with dementia diagnosed by DSM-IV criteria and the non-dementia group (PDND) who did not meet the criteria for dementia. PDD contained 30 cases and PDND contained 22 cases. Detailed patient profiles are given in Table 1 . Hoehn-Yahr stage was that in on-stage. Ten healthy controls were also studied. We used one-way ANOVA for comparison of age and Kruskal-Wallis method for comparison of gender distribution among the three groups. If variables were not applicable to the control group, MannWhitney U test was used for nonparametric data and unpaired t-test was used for parametric data in comparison between the PDD and PDND groups. Significance was accepted at p<0.05.
SPECT
Measurements were carried out in a quiet and dimly lit room with the subjects at rest in the supine position with their eyes closed. The participants did not take any medications from the night before measurements. SPECT imaging was performed using Starcam3000XR/T (General Electric Company). The resolution was 10.5 mm full width half maximum, and the computer slice width was 6 mm. The SPECT data were obtained in a 128×128 format for 64 angles with 30 seconds per angle. The study was initiated 15 minutes after intravenous injection of 167 MBq of 123 I-IMP, and each total period of data acquisition was 32 minutes. The filtered back-projection method was used for image reconstruction after preprocessing projection data with a Butterworth filter. A series of slices was reconstructed parallel to the orbitomeatal line.
Region of interest (ROI) analysis
We used anatomically standardized images and automatically set ROIs at the same areas in all images to decrease the influence of cortical atrophy and to exclude bias from a manual procedure. We used the computer software iSSP3 (Nihon Medi-Physics Co., Ltd.) for data analysis and standardization of the images (15) . ROIs were set as shown in Fig. 1 . It is a common practice in SPECT analysis to normalize a data set to a reference region. In the present work, we used the formula:
Normalized perfusion rate = (perfusion rate (right) + perfusion rate (left))/(2×cerebellar perfusion rate).
Using this normalization formula, the method was applicable to nonquantitative reconstructed image sets.
Statistical analysis
First, we used ANOVA to compare SPECT parameters among the three groups and Post-hoc analysis was performed by Fisher's PLSD (Protected Least Significant Difference). Second, we used multiple logistic regression analysis in comparison between PDD and PDND. Hoehn-Yahr stage, age, sex, disease duration, levodopa dosage, agonist use, frontal, parietal, temporal and occipital perfusion were enrolled in variables for logistic regression analysis.
Results (Tables 2, 3)
ANOVA showed significant differences in parietal, temporal and occipital perfusion among the three groups. Posthoc analysis showed a significant temporal perfusion difference between the control group and PDD. Parietal perfusion significantly differed between PDD and PDND or the control group. Occipital perfusion significantly differed between any groups. There was no significant difference in frontal perfusion.
Comparison between PDD and PDND by multiple logistic regression analysis showed differences in occipital perfusion and dopamine agonist use. Second, we analyzed the correlations between occipital perfusion and HDS-R, MMSE and FAB. As a result, MMSE showed a significant correlation with occipital perfusion (r=0.3440 p=0.0179) (Fig. 2) , but neither HDS-R nor FAB had (HDS-R: p=0.6104, FAB: p=0.4165).
Discussion
Kovari et al (16) reported that an assessment of Lewy body pathology limited to the entorhinal cortex and area 24 may be sufficient to predict cognition in Parkinson's disease. They also suggested that Lewy body formation in limbic areas may be crucial for the development of Parkinson's disease dementia (16) . However, there were few other pathological studies of Parkinson's disease with dementia.
Rather than pathological studies, PET and SPECT techniques have frequently been used and provide a useful approach to the study of Parkinson's disease with dementia. Although frontal lobe dysfunction has been described clinically in Parkinson's disease (17) (18) (19) (20) (21) (22) (23) , there has not been any significant frontal hypoperfusion observed either in our population or in other studies (8, 11) .
Spampinato et al reported that a significant decrease in 99 mTc-HMPAO was found in the parietal, temporal and occipital cortex of Parkinson's disease patients with dementia and this pattern of hypoperfusion was similar to that found in patients with dementia of Alzheimer type (24) . Liu et al described almost the same results (25) . However, Kuiper et al did not find such results (26) . Sawada et al used 123 I-IMP to divide Parkinson's disease patients with dementia into two groups based on those demonstrating frontal hypoperfusion and those demonstrating frontal and parietal hypoperfusion (27) . Using 99 mTc-HMPAO, Pizzolato et al found parietal hypoperfusion in Parkinson's disease patients with a low MMSE score (8) . Yamamoto reported that frontal, parietal and occipital hypoperfusion was detected in Parkinson's disease patients with dementia using 123 I-IMP SPECT (28). Antonini et al reported that using 99 mTc-ethyl cysteinate dimer ( 99 mTc-ECD), frontal hypoperfusion was detected in Parkinson's disease without dementia and in addition, parietal and temporal hypoperfusion was seen in Parkinson's disease with dementia (29) . Using 18 F-fluorodeoxyglucose PET Kuhl et al reported parietal and temporal hypometabolism in Parkinson's disease with dementia (11). Using 133Xe inhalation method, Globus et al did not find any relationship between the extent of rCBF reduction and the presence or severity of intellectual deterioration in patients with Parkinson's disease (10) .
There have been many conflicting studies. One reason for this may be that the mechanisms underlying neuronal degeneration beyond the dopaminergic system involve the presence of diffuse Lewy bodies as well as Alzheimer-type changes (30) and many factors contribute to the pathophysiology of dementia in Parkinson's disease, such as Alzheimer's disease-like mechanism, diffuse Lewy body disease-like factor or frontal dysfunction due to Parkinson's disease itself. In addition, neuropsychological features in Parkinson's disease and Alzheimer's disease are not always clear-cut (6) . Several studies have provided evidence for an overlap of histological and neurochemical cortical and subcortical lesions underlying the dementia in both diseases (30) (31) (32) (33) (34) (35) .
The variability also arises from differing methods of cognitive assessment and imaging techniques, definition of dementia and study populations. In addition, cortical atrophy may bias the regional measurement of rCBF and metabolism in dementia (36) .
Our results showed significant hypoperfusion in the occipital cortex in Parkinson's disease with dementia. That means the pathophysiology of dementia in Parkinson's disease is similar to that of diffuse Lewy body disease. There are trends in dementia with Lewy bodies for better performance than Alzheimer's disease patients on verbal memory and orientation tasks whereas performance on visual tasks, particularly recognition tasks, is more impaired than in Alzheimer's disease (37, 38) . Visual task-dominant cognitive impairment may have close relations with occipital hypoperfusion and hypometabolism in dementia in Parkinson's disease and diffuse Lewy body disease.
In Parkinson's disease with dementia, the severity of cognitive impairment shows a positive correlation with the density of cortical Lewy bodies in frontal and temporal lobes, and with the density of Lewy neurites in the hippocampal CA2 field, though not with Lewy body density in the anterior cingulate cortex or occipital lobes (39) (40) (41) . Therefore, the occipital hypoperfusion may not be due to the Lewy pathology itself, rather may be due to diaschisis effect to occipital lobes.
In this study we also demonstrated the correlation between dementia in Parkinson's disease and dopamine agonist use. It may be due to the more advanced stage in PDD than PDND.
In conclusion, we considered that the causes of dementia in Parkinson's disease may vary. By the multiple logistic regression method, we demonstrated significant hypoperfusion in the occipital cortex in Parkinson's disease with dementia, indicating that occipital hypoperfusion correlated more closely to dementia in Parkinson's disease than frontal, parietal or temporal perfusion. However, although parietal hypoperfusion did not correlate significantly to dementia in this regression model, there might be cases in which parietal hypoperfusion contributes to dementia in Parkinson's disease. Further studies are needed. 
